These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 38497794

  • 1. Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis.
    Tomasoni D, Aimo A, Porcari A, Bonfioli GB, Castiglione V, Saro R, Di Pasquale M, Franzini M, Fabiani I, Lombardi CM, Lupi L, Mazzotta M, Nardi M, Pagnesi M, Panichella G, Rossi M, Vergaro G, Merlo M, Sinagra G, Emdin M, Metra M, Adamo M.
    Eur Heart J Cardiovasc Imaging; 2024 Jun 28; 25(7):1007-1017. PubMed ID: 38497794
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients.
    Abe Y, Akamatsu K, Ito K, Matsumura Y, Shimeno K, Naruko T, Takahashi Y, Shibata T, Yoshiyama M.
    Circ J; 2018 Apr 25; 82(5):1451-1458. PubMed ID: 29553091
    [Abstract] [Full Text] [Related]

  • 3. Cluster analysis of preoperative echocardiographic findings and outcomes following left ventricular device implantation.
    Tang PC, Haft JW, Romano MA, Bitar A, Hasan R, Palardy M, Wu X, Aaronson K, Pagani FD.
    J Thorac Cardiovasc Surg; 2019 May 25; 157(5):1851-1860.e1. PubMed ID: 30739772
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tricuspid regurgitation in patients with severe mitral regurgitation and normal left ventricular ejection fraction: risk factors and prognostic implications in a cohort of 895 patients.
    Varadarajan P, Pai RG.
    J Heart Valve Dis; 2010 Jul 25; 19(4):412-9. PubMed ID: 20845886
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
    Hahn RT, Asch F, Weissman NJ, Grayburn P, Kar S, Lim S, Ben-Yehuda O, Shahim B, Chen S, Liu M, Redfors B, Medvedofsky D, Puri R, Kapadia S, Sannino A, Lindenfeld J, Abraham WT, Mack MJ, Stone GW.
    J Am Coll Cardiol; 2020 Sep 15; 76(11):1305-1314. PubMed ID: 32912445
    [Abstract] [Full Text] [Related]

  • 10. Prognostic Usefulness of Tricuspid Annular Diameter for Cardiovascular Events in Patients With Tricuspid Regurgitation of Moderate to Severe Degree.
    Kim H, Kim IC, Yoon HJ, Park HS, Cho YK, Nam CW, Han S, Hur SH, Kim YN.
    Am J Cardiol; 2018 Jun 01; 121(11):1343-1350. PubMed ID: 29580628
    [Abstract] [Full Text] [Related]

  • 11. Tricuspid regurgitation in acute heart failure: is there any incremental risk?
    Mutlak D, Lessick J, Khalil S, Yalonetsky S, Agmon Y, Aronson D.
    Eur Heart J Cardiovasc Imaging; 2018 Sep 01; 19(9):993-1001. PubMed ID: 29346535
    [Abstract] [Full Text] [Related]

  • 12. Functional Tricuspid Regurgitation Caused by Chronic Atrial Fibrillation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study.
    Utsunomiya H, Itabashi Y, Mihara H, Berdejo J, Kobayashi S, Siegel RJ, Shiota T.
    Circ Cardiovasc Imaging; 2017 Jan 01; 10(1):. PubMed ID: 28073806
    [Abstract] [Full Text] [Related]

  • 13. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation.
    Amat-Santos IJ, Castrodeza J, Nombela-Franco L, Muñoz-García AJ, Gutiérrez-Ibanes E, de la Torre Hernández JM, Córdoba-Soriano JG, Jiménez-Quevedo P, Hernández-García JM, González-Mansilla A, Ruano J, Tobar J, Del Trigo M, Vera S, Puri R, Hernández-Luis C, Carrasco-Moraleja M, Gómez I, Rodés-Cabau J, San Román JA.
    Rev Esp Cardiol (Engl Ed); 2018 May 01; 71(5):357-364. PubMed ID: 29079280
    [Abstract] [Full Text] [Related]

  • 14. Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.
    Yuyun MF, Joseph J, Erqou SA, Kinlay S, Echouffo-Tcheugui JB, Peralta AO, Hoffmeister PS, Boden WE, Yarmohammadi H, Martin DT, Singh JP.
    Europace; 2024 Jul 02; 26(7):. PubMed ID: 38812433
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lack of Increased Cardiovascular Risk due to Functional Tricuspid Regurgitation in Patients with Left-Sided Heart Disease.
    Mutlak D, Khoury E, Lessick J, Kehat I, Agmon Y, Aronson D.
    J Am Soc Echocardiogr; 2019 Dec 02; 32(12):1538-1546.e1. PubMed ID: 31624025
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.